Loading...
NPI 1710912175 · Glendale, CA · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kalust Ucar is a hematology & oncology physician provider located in Glendale, California. This profile covers 51 Medicare and 12 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Kalust Ucar |
| Address | 222 W Eulalia St Ste 100b |
| City | Glendale |
| State | CA |
| ZIP | 91204 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | July 12, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.8M |
| Medicaid | $790 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
51 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 21,600 | $40 | $928.8K |
| J0897 | Injection, denosumab, 1 mg | 23,580 | $20 | $424.4K |
| J3245 | Injection, tildrakizumab, 1 mg | 3,500 | $110 | $385K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 169,500 | $1 | $169.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,710 | $100 | $165.8K |
| Q5117 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | 5,260 | $20 | $110.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 810 | $120 | $98.1K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1,020 | $90 | $86.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 360 | $150 | $52.3K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 8,640 | $10 | $51.8K |
Showing 1–10 of 51
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 51 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
51 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 25 | 140 | 13,100 | $40 | $653.5K |
| J3245 | 11 | 20 | 4,100 | $110 | $520.4K |
| Q5117 | 1 | 10 | 5,260 | $20 | $109.3K |
| J0897 | 22 | 1,030 | 3,060 | $20 | $91.4K |
| J3490 | 89 | 320 | 80 | $190 | $49.2K |
| J2506 | 6 | 70 | 500 | $80 | $43.2K |
| J1439 | 4 | 110 | 29,230 | $1 | $42.6K |
| 96413 | 12 | 620 | 170 | $120 | $26.9K |
| 99233 | 6,882 | 11,530 | 120 | $100 | $26.2K |
| J0885 | 11 | 100 | 3,100 | $10 | $25.8K |
Showing 1–10 of 51
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 20 | $10 | $280 |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 40 | $10 | $220 |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 20 | $10 | $140 |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 10 | $10 | $130 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 30 | $1 | $30 |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 100 | $0 | $0 |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 30 | $0 | $0 |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 100 | $0 | $0 |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 40 | $0 | $0 |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 30 | $0 | $0 |
Showing 1–10 of 12
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
12 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 513 | 520 | 1,470 | $70 | $193.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,582 | 1,720 | 1,360 | $10 | $165.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 284 | 320 | 610 | $60 | $162.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 13,315 | 14,520 | 760 | $10 | $122.8K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,739 | 2,100 | 1,130 | $1 | $83.5K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 231 | 280 | 290 | $30 | $56.3K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 1,957 | 2,380 | 350 | $20 | $50.3K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 2,524 | 2,710 | 300 | $10 | $29.5K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,966 | 2,700 | 440 | $1 | $24.7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 721 | 820 | 510 | $10 | $18.4K |
Showing 1–10 of 12
Other providers in the same ZIP code as Kalust Ucar, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| H & H Drug Stores, Inc | CA | Durable Medical Equipment & Medical Supplies | $0 | $128M |
| Dignity Community Care | CA | General Acute Care Hospital | $0 | $27.7M |
| Montebello Adult Day Health Care Inc. | CA | Adult Day Care Clinic/Center | $0 | $26.7M |
| City Of Glendale Finance Division | CA | Land Ambulance | $2.1M | $6.8M |
| Biomed Lab | CA | Clinical Medical Laboratory | $2M | $49.6K |
| Don Lee | CA | Interventional Cardiology Physician | $1.9M | $35K |
| Michael Bublik | CA | Facial Plastic Surgery Physician | $1.2M | $0 |
| Samvel Hmayakyan | CA | Family Medicine Physician | $908.1K | $268.2K |
| Joseph Addiego | CA | Podiatrist | $1.1M | $0 |
| Linh Chen | CA | Diagnostic Radiology Physician | $842.4K | $16.8K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.